Loading Complete
Michael W Schuster, MD
Hematology OncologyHematology
Video Visit
Highlights
Languages
- English
Gender
MaleAbout Michael W Schuster
About
Revolutionary new treatments are now widely available for blood cancers, using the patient's own immune system to destroy cancer cells. Therapies such as bi-specific antibodies, CAR T cells and other types of antibodies conjugated with chemotherapy drugs have produced results never previously seen. Understanding the growth and signaling mechanisms inside cancer cells has also led to targeted drugs that have resulted in what we can honestly call "miraculous" treatments. I have been fortunate to be involved in clinical trials helping to bring these drugs into clinical practice and look forward to continued research in these areas.
Academic Title
Clinical Professor of Medicine
Publications
- Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells.
Pinz K | Liu H | Golightly M | Jares A | Lan F | Zieve GW | Hagag N | Schuster M | Firor AE | Jiang X | Ma Y
Leukemia
2016 Mar - Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment.
Gergis U | Kuriakose E | Shore T | Mayer S | Mark T | Pearse R | Schuster M | Feldman E | Roboz G | Ritchie E | Scandura J | Wang H | Zhou XK | Silver RT | van Besien K
Clinical lymphoma, myeloma & leukemia
2016 Feb 18 - Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation.
Ballen KK | Logan BR | Laughlin MJ | He W | Ambruso DR | Armitage SE | Beddard RL | Bhatla D | Hwang WY | Kiss JE | Koegler G | Kurtzberg J | Nagler A | Oh D | Petz LD | Price TH | Quinones RR | Ratanatharathorn V | Rizzo JD | Sazama K | Scaradavou A | Schuster MW | Sender LS | Shpall EJ | Spellman SR | Sutton M | Weitekamp LA | Wingard JR | Eapen M
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
2015 Apr - A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
Parmar SR | Bhatt V | Yang J | Zhang Q | Schuster M
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
2014 Jun - JAAD grand rounds quiz. Bullae and nodules on the legs of a 57-year-old woman.
Ventarola DJ | Schuster MW | Cohen JA | Silverstein DI
Journal of the American Academy of Dermatology
2014 Nov - Histone lysine-specific demethylase 1 (LSD1) protein is involved in Sal-like protein 4 (SALL4)-mediated transcriptional repression in hematopoietic stem cells.
Liu L | Souto J | Liao W | Jiang Y | Li Y | Nishinakamura R | Huang S | Rosengart T | Yang VW | Schuster M | Ma Y | Yang J
The Journal of biological chemistry
2013 Nov 29 - Fluorodeoxyglucose PET-CT Findings Following Bone Marrow Harvesting.
Matthews R | Schuster M | Safaie E | Relan N | Franceschi D
World journal of nuclear medicine
2012 Jan - Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantation.
Giralt SA | Mangan KF | Maziarz RT | Bubalo JS | Beveridge R | Hurd DD | Mendoza FL | Rubenstein EB | DeGroot TJ | Schuster MW
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
2011 Apr - Nutritional recommendations for the management of sarcopenia.
Morley JE | Argiles JM | Evans WJ | Bhasin S | Cella D | Deutz NE | Doehner W | Fearon KC | Ferrucci L | Hellerstein MK | Kalantar-Zadeh K | Lochs H | MacDonald N | Mulligan K | Muscaritoli M | Ponikowski P | Posthauer ME | Rossi Fanelli F | Schambelan M | Schols AM | Schuster MW | Anker SD
Journal of the American Medical Directors Association
2010 Jul - Response to second-line therapy defines the potential for cure in patients with recurrent diffuse large B-cell lymphoma: implications for the development of novel therapeutic strategies.
Elstrom RL | Martin P | Ostrow K | Barrientos J | Chadburn A | Furman R | Ruan J | Shore T | Schuster M | Cerchietti L | Melnick A | Coleman M | Leonard JP
Clinical lymphoma, myeloma & leukemia
2010 Jun - Impact of high-dose chemotherapy on the ability to deliver subsequent local-regional radiotherapy for breast cancer: analysis of Cancer and Leukemia Group B Protocol 9082.
Marks LB | Cirrincione C | Fitzgerald TJ | Laurie F | Glicksman AS | Vredenburgh J | Prosnitz LR | Shpall EJ | Crump M | Richardson PG | Schuster MW | Ma J | Peterson BL | Norton L | Seagren S | Henderson IC | Hurd DD | Peters WP
International journal of radiation oncology, biology, physics
2010 Apr - Report of a pilot, double-blind, placebo-controlled study of megestrol acetate in elderly dialysis patients with cachexia.
Yeh SS | Marandi M | Thode HC Jr | Levine DM | Parker T | Dixon T | Schuster MW
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation
2010 Jan - Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement.
Martin PJ | Bachier CR | Klingemann HG | McCarthy PL | Szabolcs P | Uberti JP | Schuster MW | Weisdorf D | Chao NJ | Kebriaei P | Shpall EJ | Macmillan ML | Soiffer RJ
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
2009 Jul - Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease.
Kebriaei P | Isola L | Bahceci E | Holland K | Rowley S | McGuirk J | Devetten M | Jansen J | Herzig R | Schuster M | Monroy R | Uberti J
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
2009 Jul - Usage of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly.
Yeh SS | Lovitt S | Schuster MW
The journal of nutrition, health & aging
2009 May - Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline.
Richardson PG | Sonneveld P | Schuster MW | Stadtmauer EA | Facon T | Harousseau JL | Ben-Yehuda D | Lonial S | Goldschmidt H | Reece D | Blade J | Boccadoro M | Cavenagh JD | Boral AL | Esseltine DL | Wen PY | Amato AA | Anderson KC | San Miguel J
British journal of haematology
2009 Mar - Impact of prior therapies on the relative efficacy of bortezomib compared with dexamethasone in patients with relapsed/refractory multiple myeloma.
Vogl DT | Stadtmauer EA | Richardson PG | Sonneveld P | Schuster MW | Irwin D | Facon T | Harousseau JL | Boral A | Neuwirth R | Anderson KC
British journal of haematology
2009 Nov - Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies.
Martin P | Chadburn A | Christos P | Furman R | Ruan J | Joyce MA | Fusco E | Glynn P | Elstrom R | Niesvizky R | Feldman EJ | Shore TB | Schuster MW | Ely S | Knowles DM | Chen-Kiang S | Coleman M | Leonard JP
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
2008 Jul - Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myeloma.
Mark T | Stern J | Furst JR | Jayabalan D | Zafar F | LaRow A | Pearse RN | Harpel J | Shore T | Schuster MW | Leonard JP | Christos PJ | Coleman M | Niesvizky R
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
2008 Jul - The cytokine basis of cachexia and its treatment: are they ready for prime time?
Yeh SS | Blackwood K | Schuster MW
Journal of the American Medical Directors Association
2008 May - Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant.
Schuster MW | Shore TB | Harpel JG | Greenberg J | Jalilizeinali B | Possley S | Gerwien RW | Hahne W | Halvorsen YD
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
2008 May - Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study.
San-Miguel JF | Richardson PG | Sonneveld P | Schuster MW | Irwin D | Stadtmauer EA | Facon T | Harousseau JL | Ben-Yehuda D | Lonial S | Goldschmidt H | Reece D | Blade J | Boccadoro M | Cavenagh JD | Neuwirth R | Boral AL | Esseltine DL | Anderson KC
Leukemia
2008 Apr - BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.
Niesvizky R | Jayabalan DS | Christos PJ | Furst JR | Naib T | Ely S | Jalbrzikowski J | Pearse RN | Zafar F | Pekle K | Larow A | Lent R | Mark T | Cho HJ | Shore T | Tepler J | Harpel J | Schuster MW | Mathew S | Leonard JP | Mazumdar M | Chen-Kiang S | Coleman M
Blood
2008 Feb 1 - Cachexia: a new definition.
Evans WJ | Morley JE | Argiles J | Bales C | Baracos V | Guttridge D | Jatoi A | Kalantar-Zadeh K | Lochs H | Mantovani G | Marks D | Mitch WE | Muscaritoli M | Najand A | Ponikowski P | Rossi Fanelli F | Schambelan M | Schols A | Schuster M | Thomas D | Wolfe R | Anker SD
Clinical nutrition (Edinburgh, Scotland)
2008 Dec - Bortezomib is associated with better health-related quality of life than high-dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX study.
Lee SJ | Richardson PG | Sonneveld P | Schuster MW | Irwin D | San Miguel JF | Crawford B | Massaro J | Dhawan R | Gupta S | Anderson KC
British journal of haematology
2008 Nov - Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma.
Lonial S | Richardson PG | San Miguel J | Sonneveld P | Schuster MW | Blade J | Cavenagh J | Rajkumar SV | Jakubowiak AJ | Esseltine DL | Anderson KC | Harousseau JL
British journal of haematology
2008 Oct - Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study.
Chanan-Khan A | Sonneveld P | Schuster MW | Stadtmauer EA | Facon T | Harousseau JL | Ben-Yehuda D | Lonial S | Goldschmidt H | Reece D | Neuwirth R | Anderson KC | Richardson PG
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2008 Oct 10 - The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma.
Niesvizky R | Richardson PG | Rajkumar SV | Coleman M | Rosinol L | Sonneveld P | Schuster MW | Irwin D | Stadtmauer EA | Facon T | Harousseau JL | Boral AL | Esseltine DL | Anderson KC | Blade J
British journal of haematology
2008 Oct - Utility of bortezomib retreatment in relapsed or refractory multiple myeloma patients: a multicenter case series.
Wolf J | Richardson PG | Schuster M | LeBlanc A | Walters IB | Battleman DS
Clinical advances in hematology & oncology : H&O
2008 Oct - Pharmacological treatment of geriatric cachexia: evidence and safety in perspective.
Yeh SS | Lovitt S | Schuster MW
Journal of the American Medical Directors Association
2007 Jul - Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma.
Richardson PG | Sonneveld P | Schuster MW | Irwin D | Stadtmauer EA | Facon T | Harousseau JL | Ben-Yehuda D | Lonial S | San Miguel JF | Cavenagh JD | Anderson KC
British journal of haematology
2007 Jun - Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial.
Richardson PG | Sonneveld P | Schuster M | Irwin D | Stadtmauer E | Facon T | Harousseau JL | Ben-Yehuda D | Lonial S | Goldschmidt H | Reece D | Miguel JS | Blade J | Boccadoro M | Cavenagh J | Alsina M | Rajkumar SV | Lacy M | Jakubowiak A | Dalton W | Boral A | Esseltine DL | Schenkein D | Anderson KC
Blood
2007 Nov 15 - Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials.
Jagannath S | Richardson PG | Sonneveld P | Schuster MW | Irwin D | Stadtmauer EA | Facon T | Harousseau JL | Cowan JM | Anderson KC
Leukemia
2007 Jan - A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy.
Shore T | Harpel J | Schuster MW | Roboz GJ | Leonard JP | Coleman M | Feldman EJ | Silver RT
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
2006 Aug - Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib.
Richardson PG | Briemberg H | Jagannath S | Wen PY | Barlogie B | Berenson J | Singhal S | Siegel DS | Irwin D | Schuster M | Srkalovic G | Alexanian R | Rajkumar SV | Limentani S | Alsina M | Orlowski RZ | Najarian K | Esseltine D | Anderson KC | Amato AA
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2006 Jul 1 - Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome.
Roboz GJ | Giles FJ | List AF | Cortes JE | Carlin R | Kowalski M | Bilic S | Masson E | Rosamilia M | Schuster MW | Laurent D | Feldman EJ
Leukemia
2006 Jun - Subsequent therapy can be administered after tositumomab and iodine I-131 tositumomab for non-Hodgkin lymphoma.
Dosik AD | Coleman M | Kostakoglu L | Furman RR | Fiore JM | Muss D | Niesvizky R | Shore T | Schuster MW | Stewart P | Vallabhajosula S | Goldsmith SJ | Leonard JP
Cancer
2006 Feb 1 - Megestrol acetate in cachexia and anorexia.
Yeh SS | Schuster MW
International journal of nanomedicine
2006 - Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma.
Leonard JP | Coleman M | Kostakoglu L | Chadburn A | Cesarman E | Furman RR | Schuster MW | Niesvizky R | Muss D | Fiore J | Kroll S | Tidmarsh G | Vallabhajosula S | Goldsmith SJ
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2005 Aug 20 - Bortezomib or high-dose dexamethasone for relapsed multiple myeloma.
Richardson PG | Sonneveld P | Schuster MW | Irwin D | Stadtmauer EA | Facon T | Harousseau JL | Ben-Yehuda D | Lonial S | Goldschmidt H | Reece D | San-Miguel JF | Blade J | Boccadoro M | Cavenagh J | Dalton WS | Boral AL | Esseltine DL | Porter JB | Schenkein D | Anderson KC
The New England journal of medicine
2005 Jun 16 - Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.
Peters WP | Rosner GL | Vredenburgh JJ | Shpall EJ | Crump M | Richardson PG | Schuster MW | Marks LB | Cirrincione C | Norton L | Henderson IC | Schilsky RL | Hurd DD
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2005 Apr 1 - Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results.
Leonard JP | Coleman M | Ketas JC | Chadburn A | Furman R | Schuster MW | Feldman EJ | Ashe M | Schuster SJ | Wegener WA | Hansen HJ | Ziccardi H | Eschenberg M | Gayko U | Fields SZ | Cesano A | Goldenberg DM
Clinical cancer research : an official journal of the American Association for Cancer Research
2004 Aug 15 - Risk factors relating blood markers of inflammation and nutritional status to survival in cachectic geriatric patients in a randomized clinical trial.
Yeh SS | Hafner A | Chang CK | Levine DM | Parker TS | Schuster MW
Journal of the American Geriatrics Society
2004 Oct - The emergence of Ph-, trisomy -8+ cells in patients with chronic myeloid leukemia treated with imatinib mesylate.
Feldman E | Najfeld V | Schuster M | Roboz G | Chadburn A | Silver RT
Experimental hematology
2003 Aug - Relationship between body composition and cytokines in cachectic patients with chronic obstructive pulmonary disease.
Yeh SS | Hafner A | Schuster MW | Mantovani G | Levine DM | Parker TS
Journal of the American Geriatrics Society
2003 Jun - The refractory patient: new treatment options.
Schuster MW
Oncology (Williston Park, N.Y.)
2003 Oct - The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation.
Schuster MW | Beveridge R | Frei-Lahr D | Abboud CN | Cruickshank S | Macri M | Menchaca D | Holden J | Waller EK
Experimental hematology
2002 Sep - Return of fertility after autologous stem cell transplantation.
Hershlag A | Schuster MW
Fertility and sterility
2002 Feb - Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.
Kantarjian H | Sawyers C | Hochhaus A | Guilhot F | Schiffer C | Gambacorti-Passerini C | Niederwieser D | Resta D | Capdeville R | Zoellner U | Talpaz M | Druker B | Goldman J | O'Brien SG | Russell N | Fischer T | Ottmann O | Cony-Makhoul P | Facon T | Stone R | Miller C | Tallman M | Brown R | Schuster M | Loughran T | Gratwohl A | Mandelli F | Saglio G | Lazzarino M | Russo D | Baccarani M | Morra E
The New England journal of medicine
2002 Feb 28 - Risk factors for osteoporosis in a subgroup of elderly men in a Veterans Administration nursing home.
Yeh SS | Phanumas D | Hafner A | Schuster MW
Journal of investigative medicine : the official publication of the American Federation for Clinical Research
2002 Nov - Stem cell transplantation and hematopoietic growth factors.
Richard S | Schuster MW
Current hematology reports
2002 Nov - Efficacy and safety of gemtuzumab ozogamicin in patients with poor-prognosis acute myeloid leukemia.
Roboz GJ | Knovich MA | Bayer RL | Schuster MW | Seiter K | Powell BL | Woodruff RD | Silver RT | Frankel AE | Feldman EJ
Leukemia & lymphoma
2002 Oct - Novel therapeutics for chemotherapy-resistant acute myeloid leukaemia.
Frankel AE | Schuster MW | Jurcic JG
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
2001 - Infectious complications the year after autologous bone marrow transplantation or peripheral stem cell transplantation for treatment of breast cancer.
Barton T | Collis T | Stadtmauer E | Schuster M
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2001 Feb 1 - The correlation of cytokine levels with body weight after megestrol acetate treatment in geriatric patients.
Yeh SS | Wu SY | Levine DM | Parker TS | Olson JS | Stevens MR | Schuster MW
The journals of gerontology. Series A, Biological sciences and medical sciences
2001 Jan - Mobilization of peripheral-blood stem cells by concurrent administration of daniplestim and granulocyte colony-stimulating factor in patients with breast cancer or lymphoma.
DiPersio JF | Schuster MW | Abboud CN | Winter JN | Santos VR | Collins DM | Sherman JW | Baum CM
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2000 Jul - Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study.
Yeh SS | Wu SY | Lee TP | Olson JS | Stevens MR | Dixon T | Porcelli RJ | Schuster MW
Journal of the American Geriatrics Society
2000 May - A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group.
List AF | Maziarz R | Stiff P | Jansen J | Liesveld J | Andrews F | Schuster M | Wolff S | Litzow M | Karanes C | Dahlberg S | Kirkhart B | Bianco JA | Singer JW
Bone marrow transplantation
2000 Feb - Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome.
Yeh S | Wu SY | Levine DM | Parker TS | Olson JS | Stevens MR | Schuster MW
The journal of nutrition, health & aging
2000 - Geriatric cachexia: the role of cytokines.
Yeh SS | Schuster MW
The American journal of clinical nutrition
1999 Aug - Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trial.
Vose JM | Pandite AN | Beveridge RA | Geller RB | Schuster MW | Anderson JE | LeMaistre CF | Ahmed T | Granena A | Keating A | Fernandez Ranada JM | Stiff PJ | Tabbara I | Longo W | Copelan EA | Nichols C | Smith A | Topolsky DL | Bierman PJ | Lebsack ME | Lange M | Garrison L
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
1997 Apr - Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF.
Rosenfeld CS | Bolwell B | LeFever A | Taylor R | List A | Fay J | Collins R | Andrews F | Pallansch P | Schuster MW | Resta D | Levitt D | Nemunaitis J
Bone marrow transplantation
1996 Feb
Video
Locations
- Stony Brook Cancer Center - Medical Oncology BMT
- Lauterbur Drive, Stony Brook, NY 11794
- Get Directions
- phone: 631-444-3577
- fax: 631-444-2112
- Stony Brook Internists - Hematology/Oncology
- 1575 Hillside Avenue, Suite 100, New Hyde Park, NY 11040
- Get Directions
- phone: 631-638-1000
- fax: 631-865-4052
Expertise
Education
- Fellowship: Beth Israel Deaconess/Harvard Medical Center, IM-Hematology/Oncol, 1987
- Post Doctoral Fellow: Harvard Medical School, Molecular Medicine, 1987
- Residency: Beth Israel Deaconess/Harvard Medical Center, Internal Medicine, 1983
- Medical School: Geisel School of Medicine at Dartmouth, 1980
Board Certifications
- Hematology: American Board of Internal Medicine, 1986
- Internal Medicine: American Board of Internal Medicine, 1984
Insurance
Please contact the doctor's office directly to confirm acceptance of insurance.
Search plans
- (Anthem) EMP HEALTH CHOICE HMO
- (Anthem) EMP HEALTH CHOICE MEDICAID
- (Anthem) EMP HEALTH CHOICE SR
- (Emblem) HIP
- AETNA
- Affinity
- Beech Street/Multiplan/PHCS
- CIGNA PPO
- Fidelis
- GHI / MEDICARE PLUS
- GHI CBP
- Health Smart WTC
- HEALTHFIRST
- Humana Military
- MAGNACARE
- MET EMPIRE
- OXFORD
- Partners Health Plan
- Sedgwick
- UNITED HEALTHCARE
- Workers Compensation
